Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Patients who would benefit from a GLP-1 face significant challenges when it comes to access. Shortages have made it difficult ...

In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...

It seems like every day a new study emerges linking Ozempic and similar drugs to new health benefits. Ozempic is part of a drug class known as GLP-1 medications, which mimic gut hormones that help ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational ...

A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief executive officer Michele Buck told analysts in a conference call on ...

It's also worth noting that ex-GLP 1 subgrowth would have been 40% y/y ... HIMS), the maker of prescription compound drugs ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.